March 30, 2016
Neuroseries event in Washington, DC, 30 March 2016: Join a scientist who leads the National Institute on Drug Abuse, a physician, and a policy maker from a jurisdiction where recreational marijuana has been legalized to address what science reveals about the effects of cannabis on the human brain and behavior, the status and evidence of its medicinal value, and what the implications are for policies that legalize the use of marijuana for medicinal and/or recreational uses.
October 27, 2015
Neuroseries event in Washington, DC, 27 Oct 2015: What are the circumstances necessary to produce a cultural environment that nurtures creativity? What is the role of epiphanies in the creative thinking process? How can science contribute to enhanced creativity?
September 30, 2015
Neuroseries even in Washington, DC: Unlike most disabling physical illnesses, mental illness begins very early in life, with half of all lifetime cases beginning by age 14. Advances in neuroscience and related fields have produced evidence-based treatment options, but there remain serious gaps in access by those most in need across all ages. This event focused on what we know about the causes, effects and treatments of mental illness, from young children, to adolescents, to middle-age and elderly patients. Speakers: Mark S. Frankel, Nelson B. Freimer, Anne Marie Albano, and Colleen L. Barry.
September 09, 2015
Capitol Hill Briefing, in Washington, DC: The increase in diagnoses of children with special needs has presented unique challenges in their education and development. What are leading scientists working on to confront these challenges? Panel includes Damien Fair, PA-C, PhD, of Oregon Health & Science University, Martha Denckla, MD, of Johns Hopkins University and Kennedy Krieger Institute, and Sally Shaywitz, MD, of Yale.
July 09, 2015
Capitol Hill Briefing, in Washington, DC: An overwhelming majority of felony incarcerations involve substance abuse, costing states and the federal government tens of billions of dollars. What is the correlation between drug addiction and crime, what are leading scientists working on to address this problem, and are there policy solutions to remediate this issue? Panel includes Charles O’Brien, PhD, Vice-Chair of Psychiatry at University of Pennsylvania and Director of the Prestigious Center for Studies in Addiction, and Joshua Lee, PhD, Assistant Professor in Medicine and Psychiatry at New York University Langone Medical Center. Opening remarks by The Honorable Chaka Fattah (D-PA), moderator Erin Heath of AAAS.
June 18, 2015
Page: 1 of 3
From birth to two years old is marked by great cognitive, emotional, social and physical development in children, and the brain is growing at a rapid pace. Research has enabled professionals and parents to identify developmental milestones for assessing a child’s progress across time. Although children develop according to a predictable sequence of steps, they do not necessarily proceed through them in the same way or at the same time. Every child’s development is unique, influenced by genetics, prenatal development, the care he/she receives after birth, and the experiences prompted by his or her environment. So there is a wide range of what may be considered 'normal' development. Leading scientists will review both basic and clinical research and discuss factors that influence child development from birth to two-years old, helping us understand what to look for, how to interpret what we observe, and what, if anything, can be done to intervene if something goes “wrong.” Please join us as we delve into the world of infant mental development, with Lisa Freund, Pat Levitt, Lisa Shulman, and Mark Frankel.
The Neuroscience & Society series is a partnership between The Dana Foundation and the American Association of the Advancement of Science (AAAS).